About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Beth Israel Deaconess Medical Center
›
Division of Hematology/Oncology
›
Top Articles
Division of Hematology/Oncology
Beth Israel Deaconess Medical Center
1.7K
Articles
113.2K
Citations
5.1
avg. Impact Factor
163
h-index
Most Cited Articles of Division of Hematology/Oncology in 2010
Title
Journal
Year
Citations
Design considerations for tumour-targeted nanoparticles
Nature Nanotechnology
2010
633
Rapid translocation of nanoparticles from the lung airspaces to the body
Nature Biotechnology
2010
454
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
Cancer
2010
219
Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation
Molecular Imaging
2010
213
Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a Multicenter Study
Cancer
2010
194
Nanoparticles for biomedical imaging: fundamentals of clinical translation
Molecular Imaging
2010
168
The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma
Clinical Cancer Research
2010
165
EGFR-mutated lung cancer: a paradigm of molecular oncology
Oncotarget
2010
143
Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells
Carcinogenesis
2010
129
Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation
Molecular Imaging
2010
128
Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke
PLoS ONE
2010
109
Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects
Journal of Biological Chemistry
2010
99
Real-time intra-operative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically available contrast agents
Surgery
2010
99
Real-time, near-infrared, fluorescence-guided identification of the ureters using methylene blue
Surgery
2010
97
The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in perforator flap breast reconstruction
Plastic and Reconstructive Surgery
2010
93
IL-1β-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells
Journal of Immunology
2010
86
Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis
Blood
2010
84
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer
PLoS Genetics
2010
74
Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits
Journal of Biological Chemistry
2010
71
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
Breast Cancer Research
2010
66
Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function
Journal of Clinical Investigation
2010
64
The A2aR adenosine receptor controls cytokine production in iNKT cells
European Journal of Immunology
2010
64
New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK
Clinical Cancer Research
2010
60
A phase 2 pilot trial of low-dose, continuous infusion, or "metronomic" paclitaxel and oral celecoxib in patients with metastatic melanoma
Cancer
2010
60
Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials
Oncologist
2010
58
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.